首页    期刊浏览 2024年12月02日 星期一
登录注册

文章基本信息

  • 标题:Functional assessment of the cell-autonomous role of NADase CD38 in regulating CD8 + T cell exhaustion
  • 本地全文:下载
  • 作者:Kaili Ma ; Lina Sun ; Mingjing Shen
  • 期刊名称:iScience
  • 印刷版ISSN:2589-0042
  • 出版年度:2022
  • 卷号:25
  • 期号:5
  • 页码:1-21
  • DOI:10.1016/j.isci.2022.104347
  • 语种:English
  • 出版社:Elsevier
  • 摘要:SummaryExhausted CD8+T cells with limited effector functions and high expression of multiple co-inhibitory receptors are one of the main barriers hindering antitumor immunity. The NADase CD38 has received considerable attention as a biomarker of CD8+T cell exhaustion, but it remains unclear whether the increased CD38 directly promotes T cell dysfunctionality. Here, we surprisingly found that althoughCd38deficiency partially reverses NAD+degradation and T cell dysfunctionin vitro, the terminal exhausted differentiation of adoptively transferred CD8+ T cells in tumor is not impacted by either deficiency or overexpression of CD38. Monitoring the dynamic NAD+levels shows that NAD+levels are comparable between tumor infiltrated WT andCd38−/−CD8+T cells. Therefore, our results suggest that decreased NAD+are correlated with T cell dysfunction, but deficiency of CD38 is not enough for rescuing NAD+in tumor infiltrated CD8+T cells and fails to increase the efficacy of antitumor T cell therapy.Graphical abstractDisplay OmittedHighlights•CD38 is upregulated on CD8+T cells by persistent antigen stimulation•Deletion of CD38 partially reverses NAD+degradation and T cell dysfunctionin vitro•CD38 deficiency fails to prevent or delay CD8+T cell exhaustion within tumor•NAD+levels in tumor infiltrated T cells are regulated by CD38 and other NADasesImmunology; Cell biology; Cancer
国家哲学社会科学文献中心版权所有